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Replication and pathogenesis of avian 
influenza A (H5N1) virus infection 
in polarised human bronchial and 
alveolar epithelium
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Key Messages
1. In vitro models of polarised human 
respiratory epithelial cells were 
established to investigate the 
tropism and innate host responses 
of influenza A (H5N1 and H1N1) 
viruses. 
2. Both viruses efficiently infected 
alveolar epithelial cells of both 
the apical and basolateral surfaces 
of the epithelium, whereas release 
of newly formed virus was mainly 
from the apical surface of the 
epithelium.
3. H5N1 virus was a more potent 
inducer of cytokines and 
chemokines in alveolar epithelial 
cells than H1N1 virus. Such 
chemokines were secreted onto 
both the apical and basolateral 
surfaces of the polarised alveolar 
epithelium. 
4. In bronchial epithelium, the H5N1 
virus replicated more efficiently and 
induced a stronger type I interferon 
response in the undifferentiated 
NHBE cells than did H1N1 virus. 
In contrast, in well-differentiated 
cultures, H5N1 virus replication 
was less efficient and elicited a 
lower interferon-beta response than 
did H1N1 virus. 
5. Recombinant virus with vRNPs of 
a mammalian PB2 and an avian 
PB1 had the strongest polymerase 
activities, and replicated better in 
human cell cultures, especially 
at a high incubation temperature. 
These viruses were potent inducers 
of cytokines and chemokines in 
primary human alveolar epithelial 
cells.
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Introduction
Avian influenza A (subtype H5N1) transmitted from poultry to humans in Hong 
Kong in 1997 and caused a potentially fatal human respiratory disease.1 So far, 
human-to-human transmission of the H5N1 subtype influenza virus appears to be 
inefficient, although it can cause exceptionally severe disease in 60% of humans 
it infects. Most such patients have a primary viral pneumonia complicated by 
acute respiratory distress and multiple organ dysfunction, and notably there may 
be lymphopaenia and haemophagocytosis.2,3 These haematological abnormalities 
have been ascribed to cytokine dysregulation.3-5
 The respiratory epithelial cells are the primary targets for influenza A virus 
replication.6 In primates experimentally infected with H5N1/97 virus, types I and 
II pneumocytes and alveolar macrophages were found to contain viral antigen.7 
Virus infection of alveolar pneumocytes was also demonstrated in the lung 
of a patient with fatal H5N1 disease.8 Human alveolar epithelium is vital for 
the maintenance of lung function and the pulmonary air-blood barrier. Human 
respiratory epithelial cells respond to viral infections by mounting a cytokine 
response that contributes to innate and adaptive host defences.9 In our previous 
studies, we investigated the proinflammatory cytokine profile associated with 
influenza A (H5N1) virus infection of primary monocyte-derived macrophages 
and non-polarised respiratory epithelial cells. We hypothesised that the hyper-
induction of cytokines may contribute to the unusual severity of human H5N1 
disease.
 However, the physiological relevance of findings from non-polarised and 
undifferentiated cells, as well as transformed cells lines is uncertain. It is therefore 
important to study the influenza A (H5N1) virus–cell interactions using polarised 
and differentiated respiratory epithelial cells. We aimed to (1) establish a well-
differentiated and polarised primary human respiratory epithelial cell culture 
model in vitro to study the replication and pathogenesis of avian influenza A 
(H5N1) virus disease in humans, (2) identify differences in the virus replication 
kinetics of H5N1 and H1N1 viruses in polarised human alveolar and bronchial 
epithelial cells in vitro, (3) define the contribution of different viral genes to the 
viral replication kinetics and polarisation using recombinant influenza viruses 
containing different gene combinations between human H1N1 and avian H5N1 
viruses, and (4) define the contribution of different viral genes to the cytokine 
induction profile of H1N1 and H5N1 viruses.
 
Methods
This study was conducted from March 2007 to December 2009. Primary human 
in vitro well-differentiated alveolar and bronchial epithelial cells were infected 
with influenza A (H5N1 and H1N1) viruses in vitro. Virus replication was 
monitored by measuring the levels of the influenza matrix gene, by immune-
fluorescence detection of the influenza matrix and nucleoprotein, and by 
titration of the infectious virus in MDCK cells. Using reverse genetics derived 
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Fig 1. Replication kinetics and innate host response of influenza A virus–infected polarised alveolar epithelial cells
(a) Virus titres of the A/HK/54/98 (H1N1) and A/HK/483/97 (H5N1) viruses are determined after apical and basolateral infections of the 
type I-like alveolar epithelial cells at 3 and 24 hours. At 24 hours following basolateral infection, the titre of influenza H5N1 virus at the 
apical surface of the cells is significantly more than that of H1N1 infected cells. (b) The cytokine (IFN-β and IL-6) and chemokine (RANTES 
and IP-10) gene expression from type I-like alveolar epithelial cells as well as release of RANTES and IP-10 proteins from alveolar 
epithelial cells after 24 hours of apical and basolateral infections of H1N1 and H5N1 viruses. The means and the standard errors from 
three representative experiments are shown. The dotted line represents the lowest detection limit of the TCID50 assay.
105
104
103
102
101
100
TC
ID
50
 /m
L
3 24 3 24 3 24 3 24 3 24 3 24 3 24 3 24 H1N1 H5N1
A/HK/54/98 (H1N1)
Hours post infectionHours post infection
A/HK/483/97 (H5N1)
P<0.05
P<0.05
P<0.005 P<0.005 P<0.05
Apical release after apical infection Basolateral release after apical infection
Basolateral release after basolateral infectionApical release after basolateral infection 
(a)
1000
800
600
400
200
0
600
400
200
0
400
300
200
100
0
40000
30000
20000
10000
0
60000
50000
40000
30000
20000
10000
0
1000
800
600
400
200
0
m
R
N
A 
co
pi
es
 p
er
 1
05
 β
-a
ct
in
 e
xp
re
ss
io
n
C
on
ce
nt
ra
tio
n 
(p
g/
m
L)
C
on
ce
nt
ra
tio
n 
(p
g/
m
L)
m
R
N
A 
co
pi
es
 p
er
 1
05
 β
-a
ct
in
 e
xp
re
ss
io
n
m
R
N
A 
co
pi
es
 p
er
 1
05
 β
-a
ct
in
 e
xp
re
ss
io
n
m
R
N
A 
co
pi
es
 p
er
 1
05
 β
-a
ct
in
 e
xp
re
ss
io
n
A/HK/54/98 
(H1N1)
A/HK/54/98 
(H1N1)
A/HK/54/98 
(H1N1)
A/HK/54/98 
(H1N1)
A/HK/54/98 
(H1N1)
A/HK/54/98 
(H1N1)
Mock
Mock Mock
Mock Mock
MockA/HK/483/97 
(H5N1)
A/HK/483/97 
(H5N1)
A/HK/483/97 
(H5N1)
A/HK/483/97 
(H5N1)
A/HK/483/97 
(H5N1)
A/HK/483/97 
(H5N1)
P<0.05
P<0.05
P<0.05
P<0.005
P<0.005
P<0.05
(b)
Chan et al
26      Hong Kong Med J Vol 19 No 3 Supplement 4 June 2013
Fig 2. Replication kinetics and innate host response of influenza A virus–infected well-differentiated bronchial epithelial cells
(a) Virus titres of the H1N1 and H5N1 viruses are determined after infection in the ud- and wd-NHBE cells for 1 to 48 hours at MOI of 2. 
At 24 hours post infection, viral replication kinetics of the 2 viruses are compared. (b) The IFN-β, RANTES, and IP-10 gene expression 
of the ud- and wd-NHBE cells at 6 and 24 hours post infection of H1N1 and H5N1 viruses. The means and standard errors from three 
independent experiments are shown. The dotted line represents the detection limit of the TCID50 assay.
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recombinant viruses, the role of viral PB1 and PB2 segments 
of H5N1 virus on viral replication and cytokine induction 
in the human respiratory tract was demonstrated. Gene and 
protein expression profiles (cytokine and chemokine) of 
respiratory epithelial cells infected with various influenza 
A viruses and recombinant viruses were compared by using 
real-time quantitative reverse transcriptase PCR. 
Results
Both influenza H1N1 and H5N1 viruses efficiently infected 
alveolar epithelial cells of both the apical and basolateral 
surfaces of the epithelium, whereas release of newly formed 
virus was mainly from the apical surface of the epithelium 
(Fig 1a). H5N1 virus was a more potent inducer of cytokines 
and chemokines in alveolar epithelial cells than H1N1 
virus. Such chemokines were secreted onto both the apical 
and basolateral surfaces of the polarised alveolar epithelium 
(Fig 1b). The H5N1 virus replicated more efficiently 
and induced a stronger type I interferon response in the 
undifferentiated NHBE cells than did H1N1 virus (Fig 2a). 
For other cytokines (eg RANTES and IP-10), H5N1 virus 
led to significantly higher induction of IP-10 and RANTES 
mRNA expression in ud-NHBE cells than did H1N1 or 
mock infection (Fig 2b). In contrast, in well-differentiated 
cultures, H5N1 virus replication was less efficient and 
elicited a lower interferon-beta response than did H1N1 
virus. Recombinant vRNPs with a mammalian PB2 and an 
avian PB1 had the strongest polymerase activities in human 
cells, and replicated better in cell cultures, especially at a 
high incubation temperature (Fig 3a). These viruses were 
potent inducers of cytokines and chemokines (eg RANTES 
and IP-10) in primary human alveolar epithelial cells (Fig 
3b). 
Discussion
Influenza viral infections are major causes of economic loss 
and of morbidity and mortality worldwide, and threaten 
economies and social stability as well as human health. 
These in vitro models of human respiratory epithelial cells 
enables better understanding of the transmission, prevention, 
and control of influenza A virus infections (especially 
the highly pathogenic H5N1 virus) and other emerging 
respiratory infections (such as SARS-CoV), as well as the 
underlying mechanism of inter-species transmission of 
animal pathogens to humans. These models have also been 
used to investigate the tropism and host responses of the 
swine-origin pandemic (H1N1pdm) virus. This is especially 
important when a good small animal model is lacking and 
in adherence to the 3R principles pertaining to the use of 
animals in research. Nonetheless, further investigations 
with relevant animal models of influenza virus infection 
and the potential use of immunomodulators in addition 
to antivirals may be considered. Cytokine dysregulation 
may play an important role in severe human influenza 
disease. The use of immunomodulators in combination 
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Fig 3. Characterisation of viral replication and cytokine and 
chemokine responses of recombinant viruses with chimeric 
polymerase complexes 
The origins of PB2, PB1, PA, and NP in each recombinant virus 
are shown (A=avian, M=mammalian). (a) Growth properties of 
the WSN (MMMM) and recombinant viruses in MDCK cells: the 
number of infectious progeny viral particles generated from MDCK 
cells infected with the corresponding virus at a MOI of 0.01 is 
determined by standard plaque assay. Mutant AMAA and AMMM 
are significantly attenuated. At 8 hours post infection, the amounts 
of infectious progeny of MAAA and MAMM are significantly 
higher than the wild type controls. (b) Cytokine and chemokine 
(RANTES and IP-10) gene expression profiles from primary 
human alveolar epithelial cells: total RNA from cells infected at a 
MOI of 2 is harvested at the indicated time points and tested by 
the corresponding quantitative RT-PCR. The means of triplicate 
assays and the recombinant viruses used in the experiments are 
shown.
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with antivirals may have clinical benefits. Our results may 
provide a biological basis for the observed therapeutic 
impact of immunomodulators for treating severe human 
influenza disease.
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